文献速递母胎医学产科

在受胎盘嵌合体影响的妊娠中使用游离DNA无创产前检测

Use of cell-free non-invasive prenatal testing in pregnancies affected by placental mosaicism.
PubMed 文献 · Prenat Diagn · 2024-03-23

该病例系列评估了2014年4月至2018年9月丹麦中部和北部地区胎盘嵌合体妊娠中游离DNA无创产前检测(cfNIPT)与绒毛膜绒毛取样(CVS)的配对结果。总体cfNIPT对嵌合体的检出率为45.3%(95%CI 31.8%-59.4%),罕见常染色体三体最高(56%),拷贝数变异最低(22%)。cfNIPT更常检出高水平嵌合体(p=0.000),且cfNIPT检出嵌合体的妊娠不良结局风险有升高趋势(p=0.31)。

要点

  • cfNIPT对胎盘嵌合体的总体检出率为45.3%(95%CI 31.8%-59.4%)。
  • cfNIPT检出高水平嵌合体较低水平更常见(p=0.000)。
  • cfNIPT检出嵌合体的妊娠不良结局风险有升高趋势(p=0.31)。

核心结论

  • cfNIPT对嵌合体(包括临床显著嵌合体)的检出率低,但异常cfNIPT结果可能是不良妊娠结局的预测指标。

研究设计与样本

  • 病例系列评估同一妊娠中配对cfNIPT与CVS结果,纳入2014年4月至2018年9月丹麦中部和北部地区检出的嵌合体病例。
  • CVS嵌合体涉及常见非整倍体14例、性染色体非整倍体14例、罕见常染色体三体16例和拷贝数变异(>5Mb)9例。

主要发现

  • 总体24/53(45.3%;95%CI 31.8%-59.4%)的嵌合体病例被cfNIPT检出,罕见常染色体三体检出率最高(56%),拷贝数变异最低(22%)。
  • cfNIPT检出高水平嵌合体较低水平嵌合体更常见(p=0.000)。
  • cfNIPT检出7/16(43.8%;95%CI 21%-69%)临床显著嵌合体病例(真性胎儿嵌合体或伴不良妊娠结局的局限性胎盘嵌合体)。
  • cfNIPT检出嵌合体的妊娠较未检出嵌合体的妊娠不良结局风险有升高趋势(p=0.31)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate cell-free non-invasive prenatal testing (cfNIPT) in pregnancies affected by mosaicism. METHOD: We assessed paired cfNIPT and chorionic villus sample (CVS) results from the same pregnancies in a case series of mosaicism detected in Central and North Denmark Regions from April 2014 to September 2018. Indications for the clinically obtained CVS, pregnancy markers and outcome were retrieved from The Danish Fetal Medicine Database. RESULTS: Mosaicisms in CVS involved common aneuploidy, n = 14; sex chromosomal aneuploidies, n = 14; rare autosomal trisomies (RATs), n = 16 and copy number variants (CNVs) >5Mb, n = 9. Overall, 24/53 (45.3%; CI 95%: 31.8%-59.4%) of cases with mosaicism were detected by cfNIPT; highest for RATs (56%) and lowest for CNVs (22%). CfNIPT more commonly detected high-level than low-level mosaic cases (p = 0.000). CfNIPT detected 7/16 (43.8%; CI 95%: 21%-69%) clinically significant mosaic cases, either true fetal mosaicism or confined placental mosaicisms with adverse pregnancy outcome. There was a trend toward a higher risk for adverse outcome in pregnancies where mosaicism was detected by cfNIPT compared to pregnancies where mosaicism was not detected by cfNIPT (p = 0.31). CONCLUSION: CfNIPT has a low detection rate of mosaicism, including pregnancies with clinically significant mosaicism. However, abnormal cfNIPT results may be a predictor of adverse pregnancy outcomes.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Lund ICB, Becher N, Lildballe D, et al. Use of cell-free non-invasive prenatal testing in pregnancies affected by placental mosaicism. Prenat Diagn. 2024. PMID: 38520498. doi:10.1002/pd.6558

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。